Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.3 USD | -9.91% | -4.87% | +0.20% |
04-26 | Wall Street: the worst week of 2024 is followed by the best | CF |
04-26 | Morgan Stanley Adjusts DexCom's Price Target to $132 From $122 | MT |
Chart calendar DexCom, Inc.
Upcoming events on DexCom, Inc.
Past events on DexCom, Inc.
25/04/2024 21:30 | Q1 2024 Earnings Call |
25/04/2024 21:03 | Q1 2024 Earnings Release |
08/03/2024 07:30 | Advanced Technologies and Treatments for Diabetes International Conference |
07/03/2024 13:40 | Advanced Technologies and Treatments for Diabetes International Conference |
06/03/2024 13:40 | Advanced Technologies and Treatments for Diabetes International Conference |
05/03/2024 13:40 | Raymond James Institutional Investors Conference |
08/02/2024 21:30 | Q4 2023 Earnings Call |
08/02/2024 21:02 | Q4 2023 Earnings Release |
08/01/2024 17:45 | JPMorgan Healthcare Conference |
29/11/2023 13:30 | Piper Sandler Healthcare Conference |
26/10/2023 21:30 | Q3 2023 Earnings Call |
26/10/2023 21:03 | Q3 2023 Earnings Release |
06/10/2023 09:00 | European Association for the Study of Diabetes Meeting |
03/10/2023 13:45 | European Association for the Study of Diabetes Meeting |
02/10/2023 12:30 | European Association for the Study of Diabetes Meeting |
13/09/2023 14:40 | Baird Global Healthcare Conference |
06/09/2023 20:45 | Wells Fargo Healthcare Conference |
27/07/2023 21:30 | Q2 2023 Earnings Call |
27/07/2023 21:03 | Q2 2023 Earnings Release |
23/06/2023 22:30 | Investor Day |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 476 1 466 0.72% | 1 927 1 915 0.6% | 2 449 2 449 -0.03% | 2 910 2 909 0.02% | 3 622 3 610 0.35% | 4 332 |
EBITDA Million USD | Released Forecast Spread | 210 176 19.59% | 387 377 2.59% | 473 518 -8.75% | 752 735 2.22% | 1 015 1 007 0.73% | 1 246 |
EBIT Million USD | Released Forecast Spread | 161 134 20.66% | 319 314 1.73% | 371 389 -4.61% | 485 465 4.29% | 719 687 4.59% | 868 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 104 73,5 41.82% | 225 264 -14.71% | 174 274 -36.56% | 391 374 4.38% | 710 632 12.49% | 914 |
Net income Million USD | Released Forecast Spread | 101 64,9 55.87% | 494 236 109.36% | 155 247 -37.46% | 341 365 -6.44% | 542 445 21.74% | 708 |
EPS USD | Released Forecast Spread | 0,28 0,19 48.02% | 1,27 0,56 125.21% | 0,39 0,62 -37.42% | 0,82 0,89 -8.16% | 1,30 1,09 19.66% | 1,74 |
Announcement Date | 13/02/20 | 11/02/21 | 10/02/22 | 09/02/23 | 08/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 629 624 0.76% | 696 698 -0.31% | 770 751 2.47% | 815 815 0.08% | 742 721 2.91% | 871 841 3.61% | 975 938 3.99% | 1 035 1 022 1.25% | 921 911 1.11% | 1 039 | 1 150 | 1 225 | 1 106 | 1 236 |
EBITDA Million USD | Released Forecast Spread | 112 136 -17.47% | 176 176 -0.33% | 227 196 15.56% | 237 216 9.8% | 146 140 4.34% | 233 218 6.83% | 315 258 21.89% | 322 306 5.08% | 221 215 2.56% | 286 | 356 | 388 | 299 | 360 |
EBIT Million USD | Released Forecast Spread | 50,3 73,4 -31.52% | 102 103 -0.77% | 161 138 16.42% | 172 153 12.36% | 78,6 74,8 5.06% | 158 124 27.53% | 239 174 37.54% | 243 211 15.22% | 140 128 9.21% | 188 | 256 | 288 | 190 | 245 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 36,1 63,0 -42.73% | 75,3 95,9 -21.48% | 146 128 14.1% | 133 152 -12.13% | 64,5 57,1 12.89% | 159 117 36.3% | 240 176 36.31% | 246 219 12.46% | 133 138 -4.07% | 200 | 274 | 310 | 217 | 275 |
Net income Million USD | Released Forecast Spread | 97,3 50,0 94.72% | 50,9 73,9 -31.12% | 101 96,7 4.66% | 91,8 115 -20.32% | 48,6 47,3 2.64% | 116 90,8 27.64% | 121 136 -11.05% | 256 166 54.04% | 146 103 41.96% | 153 | 206 | 234 | 156 | 205 |
EPS USD | Released Forecast Spread | 0,23 0,12 87.88% | 0,12 0,19 -37.66% | 0,24 0,26 -5.88% | 0,22 0,29 -23.26% | 0,12 0,13 -10.6% | 0,28 0,23 22.87% | 0,29 0,33 -12.52% | 0,62 0,42 46.3% | 0,36 0,26 37.73% | 0,38 | 0,51 | 0,57 | 0,38 | 0,50 |
Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | 26/10/23 | 08/02/24 | 25/04/24 | - | - | - | - | - |
Past sector events for DexCom, Inc.
26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
26/04/2024 11:00 | AVANTOR, INC.: Q1 2024 Earnings Release |
25/04/2024 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
25/04/2024 | SINOCARE INC.: Q4 2023 Earnings Release |
25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
25/04/2024 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
- Calendar DexCom, Inc.